New insights into the roles for basophils in acute and chronic allergy

Allergology International

Volumn 58, Issue 1, 2009, Pages 11-19

  Mukai, Kaori ^a   Obata, Kazushige ^a   Tsujimara, Yusuke ^a,b   Karasuyama, Hajime ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Allergic inflammation; Anaphylaxis; Basophils; IgE; IgG

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; THROMBOCYTE ACTIVATING FACTOR;

ALLERGENICITY; ALLERGIC DISEASE; ALLERGIC REACTION; ANAPHYLAXIS; ANTIGEN ANTIBODY COMPLEX; BASOPHIL; CELL COUNT; CELL FUNCTION; CELL INFILTRATION; CYTOKINE RELEASE; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MACROPHAGE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY; SKIN INFILTRATE; T LYMPHOCYTE;

EID: 65449178752     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.08-RAI-0059     Document Type: Review

References (59)

1. Galli SJ. Mast cells and basophils. Curr Opin Hematol 2000; 7:32-9.
2. Prussin C, Metcalfe DD. 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2003;111:S486-4.
3. Falcone FH, Haas H, Gibbs BF. The human basophil: a new appreciation of its role in immune responses. Blood 2000;96:4028-38.
4. Dvorak AM, Nabel G, Pyne K, Cantor H, Dvorak HF, Galli SJ. Ultrastructural identification of the mouse basophil. Blood 1982;59:1279-85.
5. Dvorak AM. The mouse basophil, a rare and rarely recognized granulocyte. Blood 2000;96:1616-7.
6. Seder RA, Paul WE, Dvorak AM et al. Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. Proc Natl Acad Sci U S A 1991;88: 2835-9.
7. Schroeder JT, MacGlashan DW Jr, Lichtenstein LM. Human basophils: mediator release and cytokine production. Adv Immunol 2001; 77:93-122.
8. Min B, Prout M, Hu-Li J et al. Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med 2004;200:507-17.
9. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004;20:267-77.
10. Min B, Paul WE. Basophils and type 2 immunity. Curr Opin Hematol 2008;15:59-63.
11. Mukai K, Matsuoka K, Taya C et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005; 23:191-202.
12. Obata K, Mukai K, Tsujimura Y et al. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 2007;110:913-20.
13. Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 2008;9:310-8.
14. Denzel A, Maus UA, Rodriguez Gomez M et al. Basophils enhance immunological memory responses. Nat Immunol 2008;9:733-42.
15. Tsujimura Y, Obata K, Mukai K et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 2008;28:581-9.
16. Sampson HA, Munoz-Furlong A, Campbell RL et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391-7.
17. Simons FE, Frew AJ, Ansotegui IJ et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 2007;120:S2-24.
18. Cohen SG, Zelaya-Quesada M. Portier, Richet, and the discovery of anaphylaxis: a centennial. J Allergy Clin Immunol 2002; 110:331-6.
19. Galli SJ. Pathogenesis and management of anaphylaxis: current status and future challenges. J Allergy Clin Immunol 2005;115:571-4.
20. Bochner BS, Lichtenstein LM. Anaphylaxis. N Engl J Med 1991; 324:1785-90.
21. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002;110:341-8.
22. Winbery SL, Lieberman PL. Histamine and antihistamines in anaphylaxis. Clin Allergy Immunol 2002;17:287-317.
23. Jacoby W, Cammarata PV, Findlay S, Pincus SH. Anaphylaxis in mast cell-deficient mice. J Invest Dermatol 1984; 83:302-4.
24. Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P. Active anaphylaxis in IgE-deficient mice. Nature 1994; 370:367-70.
25. Dombrowicz D, Flamand V, Miyajima I, Ravetch JV, Galli SJ. Kinet JP. Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 1997;99:915-25.
26. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaR III. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE-or IgG1-dependent passive anaphylaxis. J Clin Invest 1997; 99:901-14.
27. Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 2002; 109:658-68.
28. FD Finkelman. Anaphylaxis: Lessons from mouse models. J Allergy Clin Immunol 2007;120:506-15.
29. Kojima T, Obata K, Mukai K et al. Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-independent manner. J Immunol 2007; 179:7093-100.
30. Finkelman FD, Rothenberg ME, Brandt EB, Morris SC, Strait RT. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 2005; 115: 449-57; quiz 458.
31. Cheifetz A, Smedley M, Martin S et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol 2003;98:1315-24.
32. Dybendal T, Guttormsen AB, Elsayed S, Askeland B, Harboe T, Florvaag E. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia. Acta Anaesthesiol Scand 2003;47:1211-8.
33. Adourian U, Shampaine EL, Hirshman CA, Fuchs E, Adkinson NF Jr. High-titer protamine-specific IgG antibody associated with anaphylaxis: report of a case and quantitative analysis of antibody in vasectomized men. Anesthesiology 1993;78:368-72.
34. Kraft D, Hedin H, Richter W, Scheiner O, Rumpold H, Devey ME. Immunoglobulin class and subclass distribution of dextran-reactive antibodies in human reactors and non reactors to clinical dextran. Allergy 1982;37:481-9.
35. Weiss ME, Nyhan D, Peng ZK et al. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N Engl J Med 1989;320: 886-92.
36. Lie WJ, Homburg CH, Kuijpers TW et al. Regulation and kinetics of platelet-activating factor and leukotriene C4 synthesis by activated human basophils. Clin Exp Allergy 2003;33:1125-34.
37. Vadas P, Gold M, Perelman B et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008; 358:28-35.
38. Katz SI. Recruitment of basophils in delayed hypersensitivity reactions. J Invest Dermatol 1978;71:70-5.
39. Jones TD, Mote JR. The phases of foreign protein sensitized in human beings. N Engl J Med 1934;210:120-3.
40. Richerson HB, Dvorak HF, Leskowitz S. Cutaneous basophil hypersensitivity. I. A new look at the Jones-Mote reaction, general characteristics. J Exp Med 1970;132:546-57.
41. Dvorak HF, Simpson BA, Bast RC Jr, Leskowitz S. Cutaneous basophil hypersensitivity. 3. Participation of the basophil in hypersensitivity to antigen-antibody complexes, delayed hypersensitivity and contact allergy. Passive transfer. J Immunol 1971;107:138-48.
42. Graziano FM, Gunderson L, Larson L, Askenase PW. IgE antibody-mediated cutaneous basophil hypersensitivity reactions in guinea pigs. J Immunol 1983;131:2675-81.
43. Haynes JD, Rosenstein RW, Askenase PW. A newly described activity of guinea pig IgG1 antibodies: transfer of cutaneous basophil reactions. J Immunol 1978;120:886-94.
44. Matsuoka K, Taya C, Kubo S et al. Establishment of antigen-specific IgE transgenic mice to study pathological and immunobiological roles of IgE in vivo. Int Immunol 1999; 11:987-94.
45. Sato E, Hirahara K, Wada Y et al. Chronic inflammation of the skin can be induced in IgE transgenic mice by means of a single challenge of multivalent antigen. J Allergy Clin Immunol 2003;111:143-8.
46. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320: 271-7.
47. Schafer T, Heinrich J, Wjst M, Adam H, Ring J, Wichmann HE. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. J Allergy Clin Immunol 1999; 104:1280-4.
48. Busse W, Corren J, Lanier BQ et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108:184-90.
49. Holgate ST, Chuchalin AG, Hebert J et al. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy 2004;34:632-8.
50. Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol 2005; 115:459-65.
51. Macfarlane AJ, Kon OM, Smith SJ et al. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol 2000; 105:99-107.
52. Plager DA, Weiss EA, Kephart GM et al. Identification of basophils by a mAb directed against pro-major basic protein 1. J Allergy Clin Immunol 2006;117:626-34.
53. Irani AM, Huang C, Xia HZ et al. Immunohistochemical detection of human basophils in late-phase skin reactions. J Allergy Clin Immunol 1998;101:354-62.
54. Gauvreau GM, Lee JM, Watson RM, Irani AM, Schwartz LB, O'Byrne PM. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med 2000;161:1473-8.
55. Koshino T, Arai Y, Miyamoto Y et al. Airway basophil and mast cell density in patients with bronchial asthma: relationship to bronchial hyperresponsiveness. J Asthma 1996;33:89-95.
56. Nouri-Aria KT, Irani AM, Jacobson MR et al. Basophil recruitment and IL-4 production during human allergen-induced late asthma. J Allergy Clin Immunol 2001;108: 205-11.
57. Genovese A, Borgia G, Bjorck L et al. Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chains of IgE. J Immunol 2003;170:1854-61.
58. Hultsch T, Rodriguez JL, Kaliner MA, Hohman RJ. Cyclosporin A inhibits degranulation of rat basophilic leukemia cells and human basophils. Inhibition of mediator release without affecting PI hydrolysis or Ca2+ fluxes. J Immunol 1990;144:2659-64.
59. Plath KE, Grabbe J, Gibbs BF. Calcineurin antagonists differentially affect mediator secretion, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases from immunologically activated human basophils. Clin Exp Allergy 2003;33:342-50.